Blog

June 23, 2021June 22, 2021

CooperVision Specialty EyeCare Announces Uniform Markings Across Blanchard Onefit Family of Scleral Lenses

CooperVision Specialty EyeCare announced that lens markings are now uniform across the entire Blanchard Onefit™ family of scleral lenses, including Onefit™ MED and Onefit™ MED+. The uniform markings for front torics and toric haptics across the Onefit™ family aid in distinguishing whether quadrant specific landing zones and/or limbal zones have been indicated, thereby streamlining the fitting process for eye care professionals (ECPs). If quadrant specific landing zones have been indicated, the values for all four quadrants will be etched into each lens.

“We are committed to producing the highest-quality scleral lenses for the benefit of both the patient and the eye care professional,” said Marie-Christine Blanchard, Global Lead, Scleral and Irregular Cornea category for CooperVision Specialty EyeCare, Americas. “With the innovative lens design features of our Onefit™ MED and Onefit™ MED+, we are making ECPs’ lives easier. This is one of several ways we are strengthening clinical relationships and enhancing our support for the specialty eye care community.”

Further simplifying the fitting process with Onefit™ MED and Onefit™ MED+ lenses, CooperVision Specialty EyeCare has also expanded the Quadrant Specific fitting tool within its online custom tools to provide a visual depiction of the lens markings that will be seen on the final lens.

Click HERE for the full press release.

AMD Clinical Trial Update on Next-GEN Anti-VEGF Treatment

Roche has released the results of a Phase 3 trial of a next-generation anti-VEGF treatment, faricimab, for wet age-related macular degeneration (wet AMD). Anti-VEGF treatments work by blocking the VEGF molecule which promotes uncontrolled blood vessel growth in diseases like diabetic macular edema (DME) and wet age-related macular degeneration (wet AMD).

Faricimab is different because in addition to blocking VEGF, it also blocks a molecule called angiopoetin-2 (Ang-2) which also promotes blood vessel growth. There is hope is that this new treatment might be more potent than traditional anti-VEGFs because it’s attacking the problem (blood vessel growth) in two different ways. In brief, this trial showed that faricimab was as effective as another anti- VEGF (aflibercept (Eylea®)) treatment in maintaining or improving vision for patients newly diagnosed with wet AMD. 45% of patients taking faricimab were able to wait 16 weeks in between injections.

This suggests that some patients diagnosed with wet AMD may have a new treatment option that could reduce how frequently they need to get anti-VEGF injections. Importantly, there were no unexpected negative side effects. Based on the strength of this data, Roche will be submitting faricimab for approval starting with the FDA in the U.S.

June 22, 2021June 22, 2021

My Vision Show Bigger & Better: June 23-27

My Vision Show spring edition is open June 23 – 27th inclusive.

The highly interactive My Vision Show platform five feature filled days of keynote presentations, workshops, virtual exhibits and, above all else, live interaction with industry thought-leaders – all focused on the independent eye care professional.

Key daily features include,

Day 1:
- David Green – The Art of Selling Artisanal Eyewear
- Power Women’s Panel featuring Shan Khan, R.O. Editor of Optik Magazine, Industry Entrepreneurs Suzie Sendel and Charlene Nichols.
Day 2: Tom Davies introduces Catch London
Day 3: Myopia Awareness
Day 4: Live Virtual Lens Lab Tour
Day 5: Barry Santini Presents: “How to Create, Customize and Fit Bespoke Eyewear“

The My Vision Show Lounge will be open for the entire 5-day event to meet up, face to face, with friends and colleagues.

The Exhibit Area will host nearly 40 vendors, all of which are focused on the success of independent eye care and eyewear professionals.

Show specials will also be available.

NO COST TO ATTEND THIS EVENT

Click HERE to register

This is a sponsored post by My Vision Show.

June 22, 2021June 17, 2021

CORE Summarizes BCLA CLEAR Guidance for Contact Lens Practitioners

The latest issue of Contact Lens Update, now available for free from the Centre for Ocular Research & Education (CORE), consolidates conclusions from the new British Contact Lens Association’s (BCLA) Contact Lens Evidence-based Academic Reports (CLEAR) initiative into an easy-to-read summary for contact lens practitioners.

“CLEAR brought together 10 committees and more than 100 authors from 16 countries to produce 300 pages of scientific review. This covered all aspects of contact lens practice, from routine fitting through to specialty lenses, management of complications, and future technology,” said Karen Walsh, CORE’s education team leader and editor of Contact Lens Update. “Our BCLA-commissioned summary of all ten sub-reports extracts and explains the insights most relevant for clinical practice in one simple guide.”

The CLEAR sub-report summary promotes best practice, evidence-based procedures and clinical decision making for contact lens patients. Found in the issue’s Feature Article section, each five-minute read provides an overview of key take aways by topic and a link to the comprehensive open access paper for further reading.

“It’s a lovely coincidence that Issue #60 of Contact Lens Update is being published during the 60^th anniversary of soft contact lens pioneer Otto Wichterle creating the very first hydrogel lenses in his kitchen. The CLEAR series paints a fascinating portrait of how far we have come in the past six decades, and the breathtaking developments on the horizon,” said Dr. Walsh.

Published six times per year, Contact Lens Update provides a global platform for unbiased clinical insights based in current research.

Click HERE for the full press release.

June 21, 2021June 21, 2021

Transitions Partners with Internationally-Recognized Quebec Painter AnnLo

Transitions Optical is partnering with AnnLo, an internationally known Quebec painter, who has opened her studio to create unique paintings inspired by depictions of vibrant colours in eyewear. Eye care professionals can also take advantage of free original June social content for their own Facebook and Instagram pages.

“Our new partnership with AnnLo demonstrates the beauty of colour by marrying AnnLo’s unique works with the vibrancy of Transitions^® lenses style colors lenses,” said Arnaud Rajchenbach, Marketing Manager at Transitions Optical. “We encourage our partners and customers to visit the Transitions Virtual Try On, which allows users to preview Transitions^® lenses style colors virtually before their appointment with an eye care professional.”

Updates on the partnership with AnnLo are available on the Transitions Optical Facebook and Instagram pages.

Click HERE for the full press release.